Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susie Lau

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|November 24, 2022
Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?Emad Matanes, Zainab Amajoud, Liron Kogan, et al.
Gynecologic Oncology Reports|December 24, 2019
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsyDavid Octeau, Jeremie Abitbol, Zainab Amajoud, et al.
Molecular Cancer Research : MCR|September 19, 2019
Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant ChemotherapyDavid Octeau, Roy Kessous, Kathleen Klein, et al.
Cancer Treatment and Research Communications|May 13, 2026
Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative reviewDohyun Kevin Kim, Mashiad Mostafa, Yelena Aizenberg, et al.
Gynecologic Oncology|April 23, 2016
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancerJosep María Del Campo, Michael Birrer, Craig Davis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 7, 2026
Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group studyXinye Serena Wang, Gregory R Pond, Sabrina Piedimonte, et al.
Gynecologic Oncology|September 1, 2014
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancerDaliah Tsoref, Stephen Welch, Susie Lau, et al.
Gynecologic Oncology|June 29, 2021
Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP)Tomer Feigenberg, Beatrice Cormier, Walter Henri Gotlieb, et al.
Psycho-Oncology|March 19, 2026
Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full TrialMelissa Henry, S Robin Cohen, Daren K Heyland, et al.
Gynecologic Oncology|July 23, 2020
Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP)Kizanee Jegatheeswaran, Beatrice Cormier, Samantha Dube, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|November 24, 2022
Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?Emad Matanes, Zainab Amajoud, Liron Kogan, et al.
Gynecologic Oncology Reports|December 24, 2019
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsyDavid Octeau, Jeremie Abitbol, Zainab Amajoud, et al.
Molecular Cancer Research : MCR|September 19, 2019
Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant ChemotherapyDavid Octeau, Roy Kessous, Kathleen Klein, et al.
Cancer Treatment and Research Communications|May 13, 2026
Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative reviewDohyun Kevin Kim, Mashiad Mostafa, Yelena Aizenberg, et al.
Gynecologic Oncology|April 23, 2016
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancerJosep María Del Campo, Michael Birrer, Craig Davis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 7, 2026
Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group studyXinye Serena Wang, Gregory R Pond, Sabrina Piedimonte, et al.
Gynecologic Oncology|September 1, 2014
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancerDaliah Tsoref, Stephen Welch, Susie Lau, et al.
Gynecologic Oncology|June 29, 2021
Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP)Tomer Feigenberg, Beatrice Cormier, Walter Henri Gotlieb, et al.
Psycho-Oncology|March 19, 2026
Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full TrialMelissa Henry, S Robin Cohen, Daren K Heyland, et al.
Gynecologic Oncology|July 23, 2020
Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP)Kizanee Jegatheeswaran, Beatrice Cormier, Samantha Dube, et al.
Pageof 11